United States Eventing Association

Adequan^® returns as The Official Joint Therapy Treatment of the USEA and Title Sponsor of the $60,000 Adequan^® USEA Advanced Final.

The United States Eventing Association (USEA) is thrilled to announce the renewed partnership with longtime supporter American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). Adequan® will return as “The Official Joint Therapy Treatment of the USEA,” the Title Sponsor of the $60,000 Adequan® USEA Advanced Final, and a Contributing Level Sponsor of the USEA American Eventing Championships (AEC).

“For over 15 years Adequan® has supported our horses and riders,” said USEA CEO Rob Burk. “Adequan® continues to invest in U.S. Eventing and they recently increased their support by offering unparalleled prize money in the Adequan® USEA Advanced Final. We are proud to have Adequan® as ‘The Official Joint Therapy of the USEA’ and we are very thankful for everything they do for the eventing community.”

As the Title Sponsor of the Adequan® USEA Advanced Final, Adequan® will generously provide $60,000 in prize money to the top finishers. The $60,000 Adequan® USEA Advanced Final will take place during the 2021 AEC on August 31 - September 5, 2021, at the Kentucky Horse Park in Lexington, Kentucky. As a Contributing Level Sponsor of the AEC, Adequan® will also provide prizes for every AEC division.

“We’re excited to continue partnering with USEA to help keep horses moving with Adequan® i.m.,” said Andy Ferrigno, Senior Director of Sales and Marketing for American Regent Animal Health. “We’re looking forward to another season of competition and camaraderie.”

About the $60,000 Adequan® USEA Advanced Final

The $60,000 Adequan® USEA Advanced Final will take place at the 2021 USEA American Eventing Championships presented by Nutrena Feeds at the Kentucky Horse Park in Lexington, Kentucky, August 31 – September 5, 2021. Thanks to Adequan’s amazing support, the Adequan^® USEA Advanced Final will bring together the country’s top riders to vie for $60,000 in prize money and the title of Adequan^® Champion. To qualify for the $60,000 Adequan® USEA Advanced Final at the AEC in 2021, competitors will need to complete a minimum of two events without cross-country jump penalties at any USEA recognized Advanced horse trials, CCI4*-S, CCI4*-L , or CCI5*-L . The qualifying period for the 2021 AEC is May 25, 2020 through August 23, 2021. Click here to learn more about the $60,000 Adequan® USEA Advanced Final.

About American Regent Animal Health

American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit ARAnimalHealth.com or call 800-458-0163.

PP-AI-US-0633 4/2021